Found: 17
Select item for more details and to access through your institution.
First-in-human study of the antibody DR5 agonist DS-8273a in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 3, p. 298, doi. 10.1007/s10637-016-0420-1
- By:
- Publication type:
- Article
Evaluation of neuropathy in patients on suramin treatment.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Paradoxical relationship between acetylator phenotype and amonafide toxicity.
- Published in:
- Clinical Pharmacology & Therapeutics, 1991, v. 50, n. 5, p. 573, doi. 10.1038/clpt.1991.183
- By:
- Publication type:
- Article
Mineralocorticoid insufficiency due to suramin therapy.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Phase I study of escalating doses of mitoxantrone and paclitaxel with granulocyte-macrophage colony stimulating factor support.
- Published in:
- Cancer (0008543X), 1996, v. 77, n. 11, p. 2308, doi. 10.1002/(SICI)1097-0142(19960601)77:11<2308::AID-CNCR19>3.0.CO;2-0
- By:
- Publication type:
- Article
Prognostic factors for survival in patients treated in phase I clinical trials.
- Published in:
- 1994
- By:
- Publication type:
- journal article
A phase I study of subcutaneous recombinant interleukin-2 and interferon alfa-2a.
- Published in:
- 1993
- By:
- Publication type:
- journal article
A phase I study of continuous infusion cilengitide in patients with solid tumors.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 2, p. 604, doi. 10.1007/s10637-010-9537-9
- By:
- Publication type:
- Article
Clinical pharmacodynamic/exposure characterisation of the multikinase inhibitor ilorasertib (ABT-348) in a phase 1 dose-escalation trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The effect of thalidomide on the pharmacokinetics of irinotecan and metabolites in advanced solid tumor patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1629, doi. 10.1007/s00280-011-1727-4
- By:
- Publication type:
- Article
A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 54, n. 6, p. 553, doi. 10.1007/s00280-004-0857-3
- By:
- Publication type:
- Article
A phase I trial of pharmacokinetic modulation of carboxyamidotriazole (CAI) with ketoconazole in patients with advanced cancer.
- Published in:
- 2004
- By:
- Publication type:
- journal article
A phase I study of suramin with once- or twice-monthly dosing in patients with advanced cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 1, p. 1, doi. 10.1007/s00280-002-0458-y
- By:
- Publication type:
- Article
Estimation of the effect of food on the disposition of oral 5-fluorouracil in combination with eniluracil.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Development of a schedule-dependent population pharmacodynamic model for rhizoxin without quantitation of plasma concentrations.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Prolonged Pharmacokinetic Interaction Between Capecitabine and a CYP2C9 Substrate, Celecoxib.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 12, p. 1632, doi. 10.1002/jcph.1476
- By:
- Publication type:
- Article